BioNTech
NEWS
Clinical-stage biotechnology company BioNTech announced a private investment of $250 million today, led by Temasek and other investors.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020.
Less than one month after the White House zeroed in on 14 vaccine candidates for COVID-19, the administration has narrowed that list even more to five potential treatments for the prevention of the novel coronavirus.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 5, 2020.
There’s plenty of news related to clinical trials related to COVID-19, but it does seem to be drowning out non-COVID-19-related clinical trials. Here’s a look.
Pfizer and Germany-based BioNTech are collaborating on a messenger RNA vaccine against SARS-CoV-2, the novel coronavirus that causes COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.
Despite the domination of the news cycle by the COVID-19 pandemic, quite a number of biopharma companies reported on non-COVID-19 clinical trials last week, although there remains plenty of ongoing trial news related to the pandemic. Here’s a look.
JOBS
IN THE PRESS